Evidence map›Paper›PMID 28049643›Full record

ArticleBlood2017

Polyphosphate nanoparticles on the platelet surface trigger contact system activation.

Johan J F Verhoef, Arjan D Barendrecht, Katrin F Nickel, Kim Dijkxhoorn, Ellinor Kenne, Linda Labberton, Owen J T McCarty, Raymond Schiffelers, Harry F Heijnen, Antoni P Hendrickx and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed
10.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 151 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Inorganic Polyphosphate and Human Diseases.Progress in molecular and subcellular biology · 2026
    Review
  7. Review
  8. Review
  9. Factor XII-driven coagulation traps bacterial infections.The Journal of experimental medicine · 2025
    Article
  10. Crystal structure of coagulation factor XII N-terminal domains 1-5.Acta crystallographica. Section D, Structural biology · 2025
    Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 4 countries.

Johan J F VerhoefDepartment of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.ORCID 0000-0003-2483-597X
Arjan D BarendrechtDepartment of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht, The Netherlands.ORCID 0000-0002-0653-5538
Katrin F NickelDepartment of Molecular Medicine and Surgery, Karolinska Institutet and University Hospital, Stockholm, Sweden.ORCID 0000-0003-1287-6766
Kim DijkxhoornDepartment of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht, The Netherlands.
Ellinor KenneDepartment of Molecular Medicine and Surgery, Karolinska Institutet and University Hospital, Stockholm, Sweden.ORCID 0000-0002-2784-5244
Linda LabbertonDepartment of Molecular Medicine and Surgery, Karolinska Institutet and University Hospital, Stockholm, Sweden.ORCID 0000-0002-1858-867X
Owen J T McCartyDepartment of Biomedical Engineering, Department of Cell & Developmental Biology, Division of Hematology & Medical Oncology, Oregon Health & Science University, Portland, OR; and.ORCID 0000-0001-9481-0124
Raymond SchiffelersDepartment of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht, The Netherlands.ORCID 0000-0002-1012-9815
Harry F HeijnenDepartment of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht, The Netherlands.ORCID 0000-0002-8819-9231
Antoni P HendrickxDepartment of Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands.
Huub SchellekensDepartment of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
Marcel H FensDepartment of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht, The Netherlands.ORCID 0000-0002-0515-8806
Steven de MaatDepartment of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht, The Netherlands.ORCID 0000-0003-1179-374X
Thomas RennéDepartment of Molecular Medicine and Surgery, Karolinska Institutet and University Hospital, Stockholm, Sweden.ORCID 0000-0003-4594-5975
Coen MaasDepartment of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht, The Netherlands.ORCID 0000-0003-4593-0976
University Medical Center Utrecht · NLKarolinska University Hospital · SEUtrecht University · NLOregon Health & Science University · US

Funding

Characterization of Coagulation Factor-platelet Interactions: Role of FXIR01HL101972 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Owen J McCarty · 2010 to 2026
$8.5M
FXI and SepsisR01GM116184 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI LUPU, FLOREA, MCCARTY, OWEN J · 2015 to 2018
$1.9M
NHLBI NIH HHS R01 HL101972NIGMS NIH HHS R01 GM116184
6 · The paper itself

Abstract

Polyphosphate is an inorganic polymer that can potentiate several interactions in the blood coagulation system. Blood platelets contain polyphosphate, and the secretion of platelet-derived polyphosphate has been associated with increased thrombus formation and activation of coagulation factor XII. However, the small polymer size of secreted platelet polyphosphate limits its capacity to activate factor XII in vitro. Thus, the mechanism by which platelet polyphosphate contributes to thrombus formation remains unclear. Using live-cell imaging, confocal and electron microscopy, we show that activated platelets retain polyphosphate on their cell surface. The apparent polymer size of membrane-associated polyphosphate largely exceeds that of secreted polyphosphate. Ultracentrifugation fractionation experiments revealed that membrane-associated platelet polyphosphate is condensed into insoluble spherical nanoparticles with divalent metal ions. In contrast to soluble polyphosphate, membrane-associated polyphosphate nanoparticles potently activate factor XII. Our findings identify membrane-associated polyphosphate in a nanoparticle state on the surface of activated platelets. We propose that these polyphosphate nanoparticles mechanistically link the procoagulant activity of platelets with the activation of coagulation factor XII.

Indexed as

Blood CoagulationBlood PlateletsCell MembraneFactor XIIHumansNanoparticlesPolyphosphatesFactor XIIPolyphosphates

Identifiers

PMID28049643
PMCPMC5364341
OpenAlexW2565710406

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.